RAJENDER APARASU to Attention Deficit Disorder with Hyperactivity
This is a "connection" page, showing publications RAJENDER APARASU has written about Attention Deficit Disorder with Hyperactivity.
Connection Strength
2.216
-
The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across Subtypes. Subst Use Misuse. 2017 08 24; 52(10):1266-1274.
Score: 0.434
-
Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD. J Atten Disord. 2019 01; 23(2):163-172.
Score: 0.393
-
Predictors of concomitant use of antipsychotics and stimulants and its impact on stimulant persistence in pediatric attention deficit hyperactivity disorder. J Manag Care Spec Pharm. 2015 Jun; 21(6):486-98.
Score: 0.383
-
Concurrent use of stimulants and second-generation antipsychotics among children with ADHD enrolled in Medicaid. Psychiatr Serv. 2015 Apr 01; 66(4):404-10.
Score: 0.371
-
Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2012 Apr; 22(2):139-48.
Score: 0.305
-
Pharmacotherapy with atomoxetine for US children and adolescents. Ann Clin Psychiatry. 2007 Jul-Sep; 19(3):175-80.
Score: 0.221
-
Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD. Psychiatr Serv. 2017 Jul 01; 68(7):681-688.
Score: 0.108